VALIANTORGNSEQ4 FY25May 30, 2025

Valiant Organics Limited

3,439words
13turns
0analyst exchanges
0executives
Key numbers — 40 extracted
17.77%
%) FY25 Revenue Break-up – Chemistries FY25 Revenue Break-up – End user Industry 11,533 10,518 17.77% 15.62% 14000 12000 10000 8000 6000 4000 2000 0 7,231 5.28% FY22 FY23 Revenue FY24 EB
15.62%
Revenue Break-up – Chemistries FY25 Revenue Break-up – End user Industry 11,533 10,518 17.77% 15.62% 14000 12000 10000 8000 6000 4000 2000 0 7,231 5.28% FY22 FY23 Revenue FY24 EBITDA Mar
5.28%
er Industry 11,533 10,518 17.77% 15.62% 14000 12000 10000 8000 6000 4000 2000 0 7,231 5.28% FY22 FY23 Revenue FY24 EBITDA Margin 50.00% 45.00% 40.00% 35.00% 30.00% 25.00% 20.00% 1
50.00%
00 12000 10000 8000 6000 4000 2000 0 7,231 5.28% FY22 FY23 Revenue FY24 EBITDA Margin 50.00% 45.00% 40.00% 35.00% 30.00% 25.00% 20.00% 15.00% 10.00% 5.00% 0.00% 7,188 7.47% FY25
45.00%
0 10000 8000 6000 4000 2000 0 7,231 5.28% FY22 FY23 Revenue FY24 EBITDA Margin 50.00% 45.00% 40.00% 35.00% 30.00% 25.00% 20.00% 15.00% 10.00% 5.00% 0.00% 7,188 7.47% FY25 Others,
40.00%
8000 6000 4000 2000 0 7,231 5.28% FY22 FY23 Revenue FY24 EBITDA Margin 50.00% 45.00% 40.00% 35.00% 30.00% 25.00% 20.00% 15.00% 10.00% 5.00% 0.00% 7,188 7.47% FY25 Others, 5% Chlo
35.00%
6000 4000 2000 0 7,231 5.28% FY22 FY23 Revenue FY24 EBITDA Margin 50.00% 45.00% 40.00% 35.00% 30.00% 25.00% 20.00% 15.00% 10.00% 5.00% 0.00% 7,188 7.47% FY25 Others, 5% Chlorination
30.00%
00 2000 0 7,231 5.28% FY22 FY23 Revenue FY24 EBITDA Margin 50.00% 45.00% 40.00% 35.00% 30.00% 25.00% 20.00% 15.00% 10.00% 5.00% 0.00% 7,188 7.47% FY25 Others, 5% Chlorination, 20%
25.00%
0 7,231 5.28% FY22 FY23 Revenue FY24 EBITDA Margin 50.00% 45.00% 40.00% 35.00% 30.00% 25.00% 20.00% 15.00% 10.00% 5.00% 0.00% 7,188 7.47% FY25 Others, 5% Chlorination, 20% Ammonoly
20.00%
31 5.28% FY22 FY23 Revenue FY24 EBITDA Margin 50.00% 45.00% 40.00% 35.00% 30.00% 25.00% 20.00% 15.00% 10.00% 5.00% 0.00% 7,188 7.47% FY25 Others, 5% Chlorination, 20% Ammonolysis, 28
15.00%
% FY22 FY23 Revenue FY24 EBITDA Margin 50.00% 45.00% 40.00% 35.00% 30.00% 25.00% 20.00% 15.00% 10.00% 5.00% 0.00% 7,188 7.47% FY25 Others, 5% Chlorination, 20% Ammonolysis, 28% Hydro
10.00%
FY23 Revenue FY24 EBITDA Margin 50.00% 45.00% 40.00% 35.00% 30.00% 25.00% 20.00% 15.00% 10.00% 5.00% 0.00% 7,188 7.47% FY25 Others, 5% Chlorination, 20% Ammonolysis, 28% Hydrogenation
Guidance — 4 items
Industries Served
opening
• • Dyes Pigments FY25 Revenue Share 47% 4 28% Hydrogenation Ortho Anisidine Para Anisidine IPPCA
Industries Served
opening
Q4-FY25 Revenue Break-up – Chemistries Others, 2% • Gross Profit for Q4 FY25 stood at INR 721 millions, with a margin of 35%, marking a significant improvement from 26% in Q4 FY24.
Industries Served
opening
For the full year FY25, the Gross Profit Margin expanded to 37%, up from 33% in FY24, driven by a favorable product mix, effective cost optimization measures, and enhanced operational efficiencies.
Industries Served
opening
Chlorination, 20% Ammonolysis, 22% Hydrogenation, 55% • Profitability returned in the latter half of the year, reflecting a positive shift in FY25 Volume Break-up – Chemistries overall performance.
Risks & concerns — 1 flagged
Robust Business Model Integrated Operations Strong Customer Relations Distinct Product Portfolio Domain Knowledge Widespread Supply Chain Strategic Location of Plants Diverse product range and client base across numerous industries and countries provides a sustainable business model in multiple chemistries by lowering product, industry, and geographical risk.
Industries Served
Speaking time
Key Products
6
Industries Served
6
Valorem Advisors Disclaimer
1
Opening remarks
Key Products
• • • • • Para ChloroPhenol (PCP) Ortho ChloroPhenol (OCP) 2,4 Di Chlorophenol (2,4 DCP) 2,6 Di ChloroPhenol (2,6 DCP) 2,4,6 Tri ChloroPhenol (2,4,6 TCP)
Industries Served
• Agro Chemicals • Cosmetics • Veterinary • Pharmaceuticals Valiant Organics Limited | Q4-2025 4 Manufacturing Footprint CHLORINATION – SARIGAM • Capacity: 18,000 MTPA • Products: PCP, OCP, 2,4 DCP, 2,6 DCP, 2,4,6 TCP AMMONOLYSIS - VAPI • • Capacity: 9,000 MTPA Products: PNA, OCPNA AMMONOLYSIS - TARAPUR • Capacity: 6,600 MTPA • Products: PNA HYDROGENATION & METHOXYLATION- JHAGADIA UNIT 1 • • Capacity: 27,000 MTPA Products: ONA/OA, PNA/PA, IPPCA, CONVERSION PRODUCTS HYDROGENATION – JHAGADIA UNIT 2 • • Capacity: 12,000 MTPA Products: PAP, PHARMA INTERMEDIATES ACETYLATION & SULPHONATION – AHMEDABAD • • Capacity: 1,800 MTPA Products: 6 ACETYL OAPSA, OA/PA ACETANILIDE, OT5SA Valiant Organics Limited | Q4-2025 5 Key Strengths Domain expertise and broad process understanding in a variety of chemistries. The executive team is made up of first-generation technocrats with more than 50 years of collective expertise. Wide supply chain provides the continuous availability of adequate and high-quali
Valorem Advisors Disclaimer
Valorem Advisors is an Independent Investor Relations Management Service company. This Presentation has been prepared by Valorem Advisors based on information and data which the Company considers reliable, but Valorem Advisors and the Company makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this Presentation. This Presentation may not be all inclusive and may not contain all of the information that you may consider material. Any liability in respect of the contents of, or any omission from, this Presentation is expressly excluded. Valorem Advisors also hereby certifies that the directors or employees of Valorem Advisors do not own any stock in personal or company capacity of the Company under review. For further details please contact our Investor Relations Representatives: VALOREM ADVISORS Mr. Anuj Sonpal Tel: +91-22-49039500 Email: valiant@valorema
← All transcriptsVALIANTORG stock page →